COMPOSITIONS AND METHODS FOR MODULATING ANGIOPOIETIN-LIKE 3 EXPRESSION
First Claim
1. A compound comprising a modified oligonucleotide and a conjugate group, wherein the modified oligonucleotide consists of 20 contiguous nucleobases complementary to an equal length portion of nucleobases 1140 to 1159 of SEQ ID NO:
- 1, wherein the nucleobase sequence of the modified oligonucleotide is at least 80% complementary to SEQ ID NO;
1; and
wherein the conjugate group comprises;
2 Assignments
0 Petitions
Accused Products
Abstract
Provided herein are methods, compounds, and compositions for reducing expression of an ANGPTL3 mRNA and protein in an animal. Also provided herein are methods, compounds, and compositions for reducing lipids and/or glucose in an animal. Such methods, compounds, and compositions are useful to treat, prevent, delay, or ameliorate any one or more of cardiovascular disease and/or metabolic disease, or a symptom thereof, in an individual in need thereof.
-
Citations
26 Claims
-
1. A compound comprising a modified oligonucleotide and a conjugate group, wherein the modified oligonucleotide consists of 20 contiguous nucleobases complementary to an equal length portion of nucleobases 1140 to 1159 of SEQ ID NO:
- 1, wherein the nucleobase sequence of the modified oligonucleotide is at least 80% complementary to SEQ ID NO;
1; and
wherein the conjugate group comprises;
- View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26)
- 1, wherein the nucleobase sequence of the modified oligonucleotide is at least 80% complementary to SEQ ID NO;
Specification